-
市场
-
产品
-
资讯
-
Moo社区
-
课堂
-
查看更多
-
功能介绍
-
费用费用透明，无最低余额限制
投资选择、功能介绍、费用相关信息由Moomoo Financial Inc.提供
- English
- 中文繁體
- 中文简体
- 深色
- 浅色
Head-To-Head Contrast: SNDL (NASDAQ:SNDL) & Curaleaf (OTCMKTS:CURLF)
Head-To-Head Contrast: SNDL (NASDAQ:SNDL) & Curaleaf (OTCMKTS:CURLF)
Curaleaf (OTCMKTS:CURLF – Get Rating) and SNDL (NASDAQ:SNDL – Get Rating) are both consumer discretionary companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, valuation, earnings, dividends, institutional ownership, profitability and analyst recommendations.
Profitability
This table compares Curaleaf and SNDL's net margins, return on equity and return on assets.
Get Curaleaf alerts:| Net Margins | Return on Equity | Return on Assets | |
| Curaleaf | -9.72% | -7.17% | -3.67% |
| SNDL | -53.71% | -8.18% | -6.93% |
Insider & Institutional Ownership
0.1% of Curaleaf shares are held by institutional investors. Comparatively, 10.7% of SNDL shares are held by institutional investors. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.
Analyst Recommendations
This is a breakdown of current ratings for Curaleaf and SNDL, as reported by MarketBeat.| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Curaleaf | 0 | 0 | 9 | 0 | 3.00 |
| SNDL | 0 | 2 | 3 | 0 | 2.60 |
Curaleaf currently has a consensus price target of $11.72, suggesting a potential upside of 196.02%. SNDL has a consensus price target of $5.20, suggesting a potential upside of 123.18%. Given Curaleaf's stronger consensus rating and higher probable upside, equities analysts plainly believe Curaleaf is more favorable than SNDL.
Valuation & Earnings
This table compares Curaleaf and SNDL's revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Curaleaf | $1.21 billion | 2.03 | -$101.73 million | ($0.18) | -22.00 |
| SNDL | $44.78 million | 8.64 | -$183.82 million | ($0.96) | -2.43 |
Curaleaf has higher revenue and earnings than SNDL. Curaleaf is trading at a lower price-to-earnings ratio than SNDL, indicating that it is currently the more affordable of the two stocks.
Summary
Curaleaf beats SNDL on 9 of the 12 factors compared between the two stocks.
About Curaleaf
(Get Rating)
Curaleaf Holdings, Inc. operates a cannabis operator in the United States. It operates in two segments, Cannabis Operations and Non-Cannabis Operations. The Cannabis Operations segment engages in the production and sale of cannabis through retail and wholesale channels. The Non-Cannabis Operations segment provides professional services, including cultivation, processing, and retail know-how and back-office administration, intellectual property licensing, real estate leasing services, and lending facilities to medical and adult-use cannabis licensees under management service agreements. It offers flowers, pre-rolls, flower pods, and dry-herb vaporizer cartridges; concentrates for vaporizing, such as pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, including distillate droppers, mints, topical balms and lotions, tinctures, lozenges, capsules, and edibles. The company also provides hemp-based CBD products. As of November 22, 2022, it operated 144 dispensaries and 29 cultivation sites in 21 states of the United States. The company was founded in 2010 and is headquartered in Wakefield, Massachusetts.
About SNDL
(Get Rating)
SNDL, Inc. is a licensed producer that crafts small-batch cannabis using state-of-the-art indoor facilities. Its brand portfolio includes Top Leaf, Sundial Cannabis, Palmetto and Grasslands. Sundial also operates the Spiritleaf retail banner. The company was founded by Stanley J. Swiatek on August 19, 2006 and is headquartered in Calgary, Canada.
Receive News & Ratings for Curaleaf Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Curaleaf and related companies with MarketBeat.com's FREE daily email newsletter.
Curaleaf (OTCMKTS:CURLF – Get Rating) and SNDL (NASDAQ:SNDL – Get Rating) are both consumer discretionary companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, valuation, earnings, dividends, institutional ownership, profitability and analyst recommendations.
Curaleaf(场外交易代码：CURLF-GET Rating)和SNDL(纳斯达克：SNDL-GET Rating)都是非必需消费品公司，但哪种业务更好？我们将根据这两家公司的风险、估值、收益、股息、机构所有权、盈利能力和分析师的建议进行对比。
Profitability
盈利能力
This table compares Curaleaf and SNDL's net margins, return on equity and return on assets.
下表比较了Curaleaf和SNDL的净利润率、股本回报率和资产回报率。
| Net Margins | Return on Equity | Return on Assets | |
| Curaleaf | -9.72% | -7.17% | -3.67% |
| SNDL | -53.71% | -8.18% | -6.93% |
| 净利润率 | 股本回报率 | 资产回报率 | |
| 库拉利夫 | -9.72% | -7.17% | -3.67% |
| SNDL | -53.71% | -8.18% | -6.93% |
Insider & Institutional Ownership
内部人与机构所有权
0.1% of Curaleaf shares are held by institutional investors. Comparatively, 10.7% of SNDL shares are held by institutional investors. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.
Curaleaf 0.1%的股份由机构投资者持有。相比之下，SNDL 10.7%的股份由机构投资者持有。强大的机构持股表明，大型基金管理公司、对冲基金和捐赠基金相信，一家公司有望实现长期增长。
Analyst Recommendations
分析师建议
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Curaleaf | 0 | 0 | 9 | 0 | 3.00 |
| SNDL | 0 | 2 | 3 | 0 | 2.60 |
| 销售评级 | 保持评级 | 购买评级 | 强劲的买入评级 | 评级分数 | |
| 库拉利夫 | 0 | 0 | 9 | 0 | 3.00 |
| SNDL | 0 | 2 | 3 | 0 | 2.60 |
Curaleaf currently has a consensus price target of $11.72, suggesting a potential upside of 196.02%. SNDL has a consensus price target of $5.20, suggesting a potential upside of 123.18%. Given Curaleaf's stronger consensus rating and higher probable upside, equities analysts plainly believe Curaleaf is more favorable than SNDL.
Curaleaf目前的普遍目标价为11.72美元，这意味着潜在的上行空间为196.02%。SNDL的普遍目标价为5.2美元，暗示潜在上涨123.18%。考虑到Curaleaf更强的共识评级和更高的上行可能性，股票分析师显然认为Curaleaf比SNDL更有利。
Valuation & Earnings
估值与收益
This table compares Curaleaf and SNDL's revenue, earnings per share (EPS) and valuation.
该表比较了Curaleaf和SNDL的收入、每股收益(EPS)和估值。
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Curaleaf | $1.21 billion | 2.03 | -$101.73 million | ($0.18) | -22.00 |
| SNDL | $44.78 million | 8.64 | -$183.82 million | ($0.96) | -2.43 |
| 总收入 | 价格/销售额比 | 净收入 | 每股收益 | 市盈率 | |
| 库拉利夫 | 12.1亿美元 | 2.03 | -1.0173亿美元 | ($0.18) | -22.00 |
| SNDL | 4478万美元 | 8.64 | -1.8382亿美元 | ($0.96) | -2.43 |
Curaleaf has higher revenue and earnings than SNDL. Curaleaf is trading at a lower price-to-earnings ratio than SNDL, indicating that it is currently the more affordable of the two stocks.
Curaleaf的收入和收益高于SNDL。Curaleaf的市盈率低于SNDL，表明它目前是两只股票中更负担得起的一只。
Summary
摘要
Curaleaf beats SNDL on 9 of the 12 factors compared between the two stocks.
Curaleaf在两只股票比较的12个因素中有9个超过了SNDL。
About Curaleaf
关于Curaleaf
(Get Rating)
(获取评级)
Curaleaf Holdings, Inc. operates a cannabis operator in the United States. It operates in two segments, Cannabis Operations and Non-Cannabis Operations. The Cannabis Operations segment engages in the production and sale of cannabis through retail and wholesale channels. The Non-Cannabis Operations segment provides professional services, including cultivation, processing, and retail know-how and back-office administration, intellectual property licensing, real estate leasing services, and lending facilities to medical and adult-use cannabis licensees under management service agreements. It offers flowers, pre-rolls, flower pods, and dry-herb vaporizer cartridges; concentrates for vaporizing, such as pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, including distillate droppers, mints, topical balms and lotions, tinctures, lozenges, capsules, and edibles. The company also provides hemp-based CBD products. As of November 22, 2022, it operated 144 dispensaries and 29 cultivation sites in 21 states of the United States. The company was founded in 2010 and is headquartered in Wakefield, Massachusetts.
Curaleaf Holdings，Inc.在美国经营着一家大麻运营商。它分为两个部门，大麻业务和非大麻业务。大麻业务部门通过零售和批发渠道从事大麻的生产和销售。非大麻业务部门提供专业服务，包括种植、加工和零售知识以及后台管理、知识产权许可、房地产租赁服务，以及根据管理服务协议向医用和成人用大麻许可证持有者提供贷款设施。它提供鲜花、预卷、花荚和干草汽化器墨盒；用于汽化的浓缩物，如预填充的汽化器墨盒和一次性汽化器笔；以及用于涂抹的浓缩物，包括蒸馏液滴管、薄荷、外用香油和乳液、酊剂、含片、胶囊和可食用食品。该公司还提供以大麻为基础的CBD产品。截至2022年11月22日，该公司在美国21个州经营着144家药房和29个种植地点。该公司成立于2010年，总部位于马萨诸塞州韦克菲尔德。
About SNDL
关于SNDL
(Get Rating)
(获取评级)
SNDL, Inc. is a licensed producer that crafts small-batch cannabis using state-of-the-art indoor facilities. Its brand portfolio includes Top Leaf, Sundial Cannabis, Palmetto and Grasslands. Sundial also operates the Spiritleaf retail banner. The company was founded by Stanley J. Swiatek on August 19, 2006 and is headquartered in Calgary, Canada.
SNDL，Inc.是一家获得许可的生产商，使用最先进的室内设施生产小批量大麻。其品牌组合包括Top Leaf、Sunial Cannabis、Palmetto和Grands。太阳表盘还经营着精灵叶零售横幅。该公司由Stanley J.Swiatek于2006年8月19日创立，总部设在加拿大卡尔加里。
Receive News & Ratings for Curaleaf Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Curaleaf and related companies with MarketBeat.com's FREE daily email newsletter.
接受Curaleaf Daily的新闻和评级-在下面输入您的电子邮件地址，通过MarketBeat.com的免费每日电子邮件时事通讯接收对Curaleaf和相关公司的最新新闻和分析师评级的每日简要摘要。
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国，moomoo上的投资产品和服务由Moomoo Financial Inc.提供，一家受美国证券交易委员会（SEC）监管的持牌主体。 Moomoo Financial Inc.是金融业监管局（FINRA）和证券投资者保护公司（SIPC）的成员。
在新加坡，moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供，该公司受新加坡金融管理局（MAS）监管(牌照号码︰CMS101000) ，持有资本市场服务牌照 (CMS) ，持有财务顾问豁免（Exempt Financial Adviser）资质。本内容未经新加坡金融管理局的审查。
在澳大利亚，moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供，该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构（AFSL No. 224663）。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件，这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大，通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供，并受加拿大投资监管机构（CIRO）监管。
在马来西亚，moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供，该公司受马来西亚证券监督委员会（SC）监管(牌照号码︰eCMSL/A0397/2024) ，持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
风险及免责提示
moomoo是Moomoo Technologies Inc.公司提供的金融信息和交易应用程序。
在美国，moomoo上的投资产品和服务由Moomoo Financial Inc.提供，一家受美国证券交易委员会（SEC）监管的持牌主体。 Moomoo Financial Inc.是金融业监管局（FINRA）和证券投资者保护公司（SIPC）的成员。
在新加坡，moomoo上的投资产品和服务是通过Moomoo Financial Singapore Pte. Ltd.提供，该公司受新加坡金融管理局（MAS）监管(牌照号码︰CMS101000) ，持有资本市场服务牌照 (CMS) ，持有财务顾问豁免（Exempt Financial Adviser）资质。本内容未经新加坡金融管理局的审查。
在澳大利亚，moomoo上的金融产品和服务是通过Futu Securities (Australia) Ltd提供，该公司是受澳大利亚证券和投资委员会(ASIC)监管的澳大利亚金融服务许可机构（AFSL No. 224663）。请阅读并理解我们的《金融服务指南》、《条款与条件》、《隐私政策》和其他披露文件，这些文件可在我们的网站 https://www.moomoo.com/au中获取。
在加拿大，通过moomoo应用提供的仅限订单执行的券商服务由Moomoo Financial Canada Inc.提供，并受加拿大投资监管机构（CIRO）监管。
在马来西亚，moomoo上的投资产品和服务是通过Moomoo Securities Malaysia Sdn. Bhd. 提供，该公司受马来西亚证券监督委员会（SC）监管(牌照号码︰eCMSL/A0397/2024) ，持有资本市场服务牌照 (CMSL) 。本内容未经马来西亚证券监督委员会的审查。
Moomoo Technologies Inc., Moomoo Financial Inc., Moomoo Financial Singapore Pte. Ltd., Futu Securities (Australia) Ltd, Moomoo Financial Canada Inc.,和Moomoo Securities Malaysia Sdn. Bhd.是关联公司。
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能，分享给你的好友吧